000566.SZ
Hainan Haiyao Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 4.52
−6.61%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 792.8M | 831.2M | 990.7M | 1.5B | 1.8B |
| Cost of Revenue | 606.7M | 625.0M | 641.7M | 908.5M | 1.0B |
| Gross Profit | 186.0M | 206.2M | 349.0M | 570.1M | 768.2M |
| Operating Expenses | |||||
| R&D Expense | 28.0M | 39.7M | 58.6M | 55.1M | 49.2M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 239.2M | 228.8M | 228.4M | 166.6M | 198.0M |
| Selling & Marketing Expense | 155.5M | 150.2M | 274.4M | 368.9M | 522.9M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 637.6M | 632.4M | 756.4M | 767.6M | 958.9M |
| Cost and Expenses | 1.2B | 1.3B | 1.4B | 1.7B | 2.0B |
| Operating Income (EBIT) | (413.5M) | (406.5M) | (1.5B) | (120.7M) | (61.5M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | (410.7M) | (407.7M) | (1.6B) | (118.6M) | (58.9M) |
| Income Tax Expense | 50.8M | 48.5M | 34.0M | 16.8M | (61.3M) |
| Bottom Line | |||||
| Net Income | (438.1M) | (430.0M) | (1.5B) | (106.5M) | 10.5M |
| Earnings from Cont. Ops | (461.5M) | (456.2M) | (1.6B) | (140.6M) | (310.3M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (438.1M) | (430.0M) | (1.5B) | (106.5M) | 10.5M |
| Per Share | |||||
| Basic EPS | (CN¥0.34) | (CN¥0.33) | (CN¥1.18) | (CN¥0.08) | CN¥0.01 |
| Diluted EPS | (CN¥0.34) | (CN¥0.33) | (CN¥1.18) | (CN¥0.08) | CN¥0.01 |
| Revenue Per Share | CN¥0.61 | CN¥0.64 | CN¥0.76 | CN¥1.14 | CN¥1.37 |
| Shares | |||||
| Basic Shares Outstanding | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B |
| Diluted Shares Outstanding | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B |
| Profitability Metrics | |||||
| EBITDA | — | (205.2M) | (1.4B) | 46.2M | 99.1M |
| D&A | — | 201.3M | 185.1M | 166.8M | 160.6M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026